New drug combo tested in Tough-to-Treat skin cancer
Disease control
Completed
This early-stage study tested a new drug called IN10018, both alone and in combination with other cancer drugs, in 51 adults with advanced melanoma that had spread. The main goal was to check the safety of these treatments and see how the body processes the drug. Researchers also…
Phase: PHASE1 • Sponsor: InxMed (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC